NIRVF (Nirvana Life Sciences) Asset Turnover: 0.00 (As of Jan. 2026)


What is Nirvana Life Sciences Asset Turnover?

Nirvana Life Sciences NIRVF Asset Turnover is 0.00 as of Jan. 2026. The stock has 3 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Nirvana Life Sciences's Revenue for the three months ended in Jan. 2026 was $0.00 Mil. Nirvana Life Sciences's Total Assets for the quarter that ended in Jan. 2026 was $0.02 Mil. Therefore, Nirvana Life Sciences's Asset Turnover for the quarter that ended in Jan. 2026 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Nirvana Life Sciences's annualized ROE % for the quarter that ended in Jan. 2026 was 18.10%. It is also linked to ROA % through Du Pont Formula. Nirvana Life Sciences's annualized ROA % for the quarter that ended in Jan. 2026 was -1,013.33%.

Nirvana Life Sciences  (OTCPK:NIRVF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Nirvana Life Sciences's annulized ROE % for the quarter that ended in Jan. 2026 is

ROE %**(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-0.152/-0.84
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.152 / 0)*(0 / 0.015)*(0.015/ -0.84)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.0179
=ROA %*Equity Multiplier
=-1,013.33 %*-0.0179
=18.10 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Nirvana Life Sciences's annulized ROA % for the quarter that ended in Jan. 2026 is

ROA %(Q: Jan. 2026 )
=Net Income/Total Assets
=-0.152/0.015
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.152 / 0)*(0 / 0.015)
=Net Margin %*Asset Turnover
= %*0
=-1,013.33 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Nirvana Life Sciences Asset Turnover Related Terms

Nirvana Life Sciences Asset Turnover Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Asset Turnover Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Asset Turnover
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NIRVF vs VRTX, REGN, ALNY: Asset Turnover Comparison

For the Biotechnology subindustry, Nirvana Life Sciences's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Asset Turnover falls into.


Nirvana Life Sciences Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Nirvana Life Sciences's Asset Turnover for the fiscal year that ended in Apr. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Apr. 2025 )/( (Total Assets (A: Apr. 2024 )+Total Assets (A: Apr. 2025 ))/ count )
=0/( (0.015+0.014)/ 2 )
=0/0.0145
=0.00

Nirvana Life Sciences's Asset Turnover for the quarter that ended in Jan. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jan. 2026 )/( (Total Assets (Q: Oct. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=0/( (0.015+0.015)/ 2 )
=0/0.015
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.00 mean?
Nirvana Life Sciences (NIRVF) has a Asset Turnover of 0.00 as of Jan. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Asset Turnover too high?
Nirvana Life Sciences' current Asset Turnover is 0.00.
How does Nirvana Life Sciences' Asset Turnover compare to VRTX and REGN?
Nirvana Life Sciences' Asset Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Asset Turnover is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.